Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, Nitayaphan S, Khamboonruang C, Kunasol P, Suntharasamai P, Pungpak S, Vanijanonta S, Bussaratid V, Maek-A-Nantawat W, Dhitavat J, Thongcharoen P, Pawarana R, Sabmee Y, Benenson M, Morgan P, O'Connell R, Kim JH. Issues in Women's Participation in a Phase III Community HIV Vaccine Trial in Thailand. AIDS Res Hum Retroviruses. 2013 Nov;29(11):1524-34.

Pollara J, Bonsignori M, Moody M, Alam S, Hwang K, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Tsao C, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Tomaras GD, Kim JH, Michael NL, Montefiori DC, Liao H, Haynes BF, Ferrari G, and the Center for HIV/AIDS Vaccine Immunology. Heterogeneity of Anti-V2 ADCC Ab Responses and Implications for Vaccine Development (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.110.

Karasavvas N, Karnasuta C, De Souza MS, Madnote S, Inthawong D, Savadsak H, Rittiroongrad S, Chantakulkij S, Nitayaphan S, Pitisuttithum P, Thongcharoen P, Siriyanon V, Andrew CA, O’Connell RJ, Michael NL, Ngauy V, Kim JH. Antibody Responses to Recombinant gp120, gp70 V1V2 Proteins and Cyclic V2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine  Regimens (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.123.

Karasavvas N, Karnasuta C, Ngauy V, Vasan S, Trichavaroj R, De Souza MS, Savadsuk H, Inthawong D, Rittiroongrad S, Madnote S, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, O’Connell RJ, Michael NL, Kim JH. Investigation of Antibody Responses Induced in RV305 a Late Boost Vaccination of HIV-1 Uninfected Volunteers that participated in RV144, a Thai Trial (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.143.

Nicely NI, Wiehe K, Kepler TB, Jaeger FH, Dennison SM, Liao H, Alam SM, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Michael NL, Kim JH, Haynes BF. Structural Analysis of the Unmutated Common Ancestor Antibodies of the HIV Envelope V2 Antibodies CH58 and CH59 Derived from RV144 Vaccinees (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.145.

Wiehe K, Easterhoff D, Luo K, Williams W, Vandergrift N, Lloyd E, Stolarchuk C, Parks R, Nicely N, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Michael N, Kim J, Tomaras G, Bonsignori M, Kepler TB, Moody AM, Liao H, Haynes BF. Phylogenetic Conservation of a Dominant Antibody Light Chain HIV Env V2 Binding Motif in Human and rhesus Macaque Antibodies (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.145.

Rolland M, Edlefsen PT, Gottardo R, Montefiori DC, Zolla-Pazner S, Moody A, Liao LH, Liu P, Tomaras GD, Haynes BF, Bailer RT, Koup RA, Mascola JR, Shen X, Korber BT, Tovanabutra S, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal J, Robb ML, Michael NL, Mullins JI, Gilbert PB, Kim JH. Genetic and Immunological Evidence for a Role of Env-V3 Antibodies in the RV144 Trial (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.146.

Chung AW, Ghebremichael M, Robinson H, Brown E, Choi I, Rolland M, Dugast A, Suscovich TJ, Liao L, Mahan AE, Streeck H, Rerks-Ngarm S, Nitayaphan S, De Souza MS, Pitisuttithum P, Francis D, Michael NL, Kim JH, Bailey-Kellog C, Ackerman ME, Alter G. Distinct HIV-Specific Antibody Fc-Profiles in RV144 and VAX003 Vaccinees (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.150.

Limwattanayingyong A, Arun-Ngamwong T, Wattanakitwichai J, Yamoon D, Debyasuvarn T, Dhitarat J,  Kaewkungwal J, Namwat C, Premsri N, Churikanont N, Excler J, O’Connell R, Eamsila C,  Kim J, Karasavvas N, Vasan S, Ngauy V, Pitisuttithum P, Rerks-Ngarm S. Acceptability and Quality of New Mucosal Secretion Collection Procedures in an HIV Vaccine Trial in Thailand (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.153.

Prentice H, Geraghty DE, Tomaras GD, Fong Y, Nelson W, Kijak GH, Zolla-Pazner S, Nitayaphan S,  Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Gilbert PB, Haynes BF, Kim JH, Michael N,  Thomas R. HLA Class II Genes Interact with the Immune Correlates from the RV144 Vaccine Efficacy Trial and Impact HIV-1 Acquisition (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.200.

Li SS, Gilbert PB, Tomaras GD, Kijak G, Ferrari G, Thomas R, Zolla-Pazner S, Evans DT, Li Y, Gottardo R, Dai JY, Janes H, Morris D, Fong Y, Edlefsen PT, Li F, Magaret CA, Frahm N, Alpert MD,  Rerks-Ngarm S, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Robb ML, O’Connell RJ,  Michael NL, Kim JH, McElrath MJ, Geraghty DE. Association of FcγRIIC Polymorphism with Vaccine Efficacy and Correlates of HIV-1 Infection Risk in RV144 (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.200.

Herrera C, Schuetz A, Olejniczak N, Assawadarachai V, Karasavva N, Nitayaphan S, Kaewkungwal J,  Ngauy V, Pitisuttithum P, Rerks-Ngarm S, Michael NL, O’Connell RJ, Excler J, Shattock RJ,  Kim JH. Preliminary Evaluation of Mucosal Immune Responses with Mucosal Explants in Humans Vaccinated with ALVAC/AIDSVAX B/E During the Ongoing RV305 Trial (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.225.

Schuetz A, Phuangngern Y, De Souza MS, Sukhumvittaya S, Jongrakthaitae S, Rerknimitr R,  Saengtawan P, Ananworanich J, Vasan S, Ratto-Kim S, Pitisuttithum P, Michael N, O’Connell RJ, Ngauy V, Rerks-Ngarm S, Kim JH. Evaluation of Peripheral and Mucosal Cellular Immune Responses Induced by Late Boost Strategies in HIV-Negative Participants Prior Enrolled in RV144 (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.269.

Seaton K, Yates N, Williams W, Liao L, deCamp A, Fong Y, Montefiori D, Spearman P, Elizaga M,  Barnett S, Koutsoukos M, Bourguignon P, McElrath J, Corey L, Michael N, Pitisuttithum P, Rerks-Ngarm S, Kim J, Voss G, Gilbert P, Haynes B, Tomaras G. Human HIV-1 Vaccine Induced Antibody Durability and Env IgG3 Responses (Abstract). AIDS Vaccine 2013, Barcelona, Spain. Oct 7-10, 2013 p.306.

Gottardo R, Bailer RT, Korber BT, Gnanakaran S, Phillips J, Shen X, Tomaras GD, Turk E, Imholte G, Eckler L, Wenschuh H, Zerweck J, Greene K, Gao H, Berman PW, Francis D, Sinangil F, Lee C, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, Robb ML, Michael NL, Kim JH, Zolla-Pazner S, Haynes BF, Mascola JR, Self S, Gilbert P, Montefiori DC. Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial. PLoS One. 2013 Sep 26;8(9):e75665.

Pitisuttithum P, Rerks-Ngarm S, O’Connell RJ, Kim JH, Excler JL. An HIV Vaccine for South-East Asia-Opportunities and Challenges. Vaccines 2013, 1(3), 348-366.

Sagaki P, Thanachartwet V, Desakorn V, Sahassananda D, Chamnanchanunt S, Chierakul W, Pitisuttithum P, Ruangkanchanasetr P. Clinical Factors for Severity of Plasmodium falciparum Malaria in Hospitalized Adults in Thailand. PLoS One. 2013 Aug 12;8(8):e71503.

Aung KLL, Thanachartwet V, Desakorn V, Chamnanchanunt S, Sahassananda D, Chierakul W, Pitisuttithum P. Factors Associated with Severe Clinical Manifestation of Dengue among Adults in Thailand. Southeast Asian J Trop Med Public Health. 2013 Jul ;44(4):602-12.

Capeding MR, Chua MN, Hadinegoro SR, Hussain I, Nallusamy R, Pitisuttithum P, Rusmil K, Thisyakorn U, Thomas SJ, Tran NH, Wirawan DN, Yoon IK, Bouckenooghe A, Hutagalung Y, Laot T, Wartel TA. Dengue and Other Common Causes of Acute Febrile Illness in Asia: An Active Surveillance Study in Children. PLoS Negl Trop Dis. 2013 Jul 13;7(7):e2331.

Pitisuttithum P, Excler JL, Kim J. Beyond RV144 Efficacy Results: An Update. Procedia in Vaccinology 7 (2013) 49 – 56.

Liu P, Yates NL, Shen X, Bonsignori M, Moody MA, Liao HX, Fong Y, Alam SM, Overman RG, Denny T, Ferrari G, Ochsenbauer C, Kappes JC, Polonis VR, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Montefiori DC, Gilbert P, Michael NL, Kim JH, Haynes BF, Tomaras GD. Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees. J Virol. 2013 Jul;87(14):7828-36.

Duangrithi D, Thanachartwet V, Desakorn V, Jitruckthai P, Phojanamongkolkij K, Rienthong S, Chuchottaworn C, Pitisuttithum P. Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand. Int J Clin Pract. 2013 Nov;67(11):1199-209.

Tomaras GD, Ferrari G, Shen X, Alam SM, Liao HX, Pollara J, Bonsignori M, Moody MA, Fong Y, Chen X, Poling B, Nicholson CO, Zhang R, Lu X, Parks R, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Gilbert PB, Kim JH, Michael NL, Montefiori DC, Haynes BF. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9019-24.

Kyaw NL, Thanachartwet V, Kiertiburanakul S, Desakorn V, Chamnanchanunt S, Chierakul W, Manosuthi W, Pitisuttithum P, Sungkanuparph S. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand. Southeast Asian J Trop Med Public Health. 2013 Mar;44(2):232-43.

Phonrat B, Pitisuttithum P, Chamnanchanunt S, Puthavathana P, Ngaosuwankul N, Louisirirotchanakul S, Dhitavat J, Thirapakpoomanunt S, Chokevivat V, Wibulpolprasert W. Safety and Immune Responses Following Administration of H1N1 Live Attenuated Influenza Vaccine in Thais. Vaccine. 2013 Mar 1;31(11):1503-9.

Liao HX, Bonsignori M, Alam SM, McLellan JS, Tomaras GD, Moody MA, Kozink DM, Hwang KK, Chen X, Tsao CY, Liu P, Lu X, Parks RJ, Montefiori DC, Ferrari G, Pollara J, Rao M, Peachman KK, Santra S, Letvin NL, Karasavvas N, Yang ZY, Dai K, Pancera M, Gorman J, Wiehe K, Nicely NI, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, Sinangil F, Kim JH, Michael NL, Kepler TB, Kwong PD, Mascola JR, Nabel GJ, Pinter A, Zolla-Pazner S, Haynes BF. Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2. Immunity. 2013 Jan 24;38(1):176-86.

Alam SM, Liao HX, Tomaras GD, Bonsignori M, Tsao CY, Hwang KK, Chen H, Lloyd KE, Bowman C, Sutherland L, Jeffries TL Jr, Kozink DM, Stewart S, Anasti K, Jaeger FH, Parks R, Yates NL, Overman RG, Sinangil F, Berman PW, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Karasavva N, Rerks-Ngarm S, Kim JH, Michael NL, Zolla-Pazner S, Santra S, Letvin NL, Harrison SC, Haynes BF. Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion. J Virol. 2013 Feb; 87(3):1554-68.

Home